0000002018-10-012018-12-310000002018-12-310000002018-04-012018-12-310000002018-10-012018-12-31in-bse-fin:OtherExpenses1Member0000002018-10-012018-12-31in-bse-fin:OtherExpenses2Member0000002018-10-012018-12-31in-bse-fin:OtherExpenses3Member0000002018-10-012018-12-31in-bse-fin:OtherExpenses4Member0000002018-10-012018-12-31in-bse-fin:OtherExpenses5Member0000002018-10-012018-12-31in-bse-fin:OtherExpenses6Member0000002018-10-012018-12-31in-bse-fin:OtherExpenses7Member0000002018-10-012018-12-31in-bse-fin:OtherExpenses8Member0000002018-10-012018-12-31in-bse-fin:OtherExpenses9Member0000002018-10-012018-12-31in-bse-fin:OtherExpenses10Member0000002018-04-012018-12-31in-bse-fin:OtherExpenses1Member0000002018-04-012018-12-31in-bse-fin:OtherExpenses2Member0000002018-04-012018-12-31in-bse-fin:OtherExpenses3Member0000002018-04-012018-12-31in-bse-fin:OtherExpenses4Member0000002018-04-012018-12-31in-bse-fin:OtherExpenses5Member0000002018-04-012018-12-31in-bse-fin:OtherExpenses6Member0000002018-04-012018-12-31in-bse-fin:OtherExpenses7Member0000002018-04-012018-12-31in-bse-fin:OtherExpenses8Member0000002018-04-012018-12-31in-bse-fin:OtherExpenses9Member0000002018-04-012018-12-31in-bse-fin:OtherExpenses10Member0000002018-10-012018-12-31in-bse-fin:ReportableSegments1Member0000002018-10-012018-12-31in-bse-fin:ReportableSegments2Member0000002018-04-012018-12-31in-bse-fin:ReportableSegments1Member0000002018-04-012018-12-31in-bse-fin:ReportableSegments2Member0000002018-10-012018-12-31in-bse-fin:ReportableSegments1Member0000002018-10-012018-12-31in-bse-fin:ReportableSegments2Member0000002018-04-012018-12-31in-bse-fin:ReportableSegments1Member0000002018-04-012018-12-31in-bse-fin:ReportableSegments2Member0000002018-10-012018-12-31in-bse-fin:ReportableSegments1Member0000002018-12-31in-bse-fin:ReportableSegments1Member0000002018-10-012018-12-31in-bse-fin:ReportableSegments2Member0000002018-12-31in-bse-fin:ReportableSegments2Member0000002018-10-012018-12-31in-bse-fin:ReportableSegments1Member0000002018-12-31in-bse-fin:ReportableSegments1Member0000002018-10-012018-12-31in-bse-fin:ReportableSegments2Member0000002018-12-31in-bse-fin:ReportableSegments2Member0000002018-10-012018-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss10000002018-04-012018-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares000000SIGACHIINE368H01018SIGACHI LABORATORIES LIMITEDEquity2018-04-012019-03-312019-02-132019-01-30INRLakhsThird quarterMulti segment2019-02-1304:00:002019-02-1305:00:002018-01-102018-12-31UnauditedStandalone4870700905200577590000060510003603002374001202800457310004573100550000320005820000399110000003991100159400055851000067531000100.5910.591000.5910.5911.The above Financial results have been reviewed by the Audit Committee and thereafter approved and taken on record by the Board of Directors at their respective Meetings held on 13th February, 2019. <BR> 2.The Statutory Auditors have Carried out the Limited Review of the Results for the quarter and nine months ended 31st December, 2018. <BR> 3.Previous year / period figures have been recasted / regrouped / reclassified wherever necessary to make them comparable with current year / period figures.2018-01-042018-12-31UnauditedStandalone108045001799600126041000001802800011214009718003896000870810008708100157500010100016760000703210000007032100-21300068191000067531000101.0411.041001.0411.041Rent33000Factory Maintenance20000Advertisement Charges9900Bank Charges800Conveyance Expenses34400Factory Insurance6200Listing Fee0Postage & Telegram100Office Maintanance31900Other expenses101100Rent99000Factory Maintenance36000Advertisement Charges39500Bank Charges10800Conveyance Expenses115300Factory Insurance80300Listing Fee55000Postage & Telegram158300Office Maintanance95100Other expenses282500Bulk Drugs and Intermediates2600000Investments3176000Bulk Drugs and Intermediates6850000Investments575400057760001260400000577600012604000Bulk Drugs and Intermediates2213000Investments3176000Bulk Drugs and Intermediates5612000Investments575400053890001136600000816000265800045730008708000Bulk Drugs and Intermediates46779900Investments1711270002179069000217906900Bulk Drugs and Intermediates13009000Investments013009000013009000Items that will not be reclassified to profit or loss15940001594000Items that will not be reclassified to profit or loss-213000-2130000000